Matinas Biopharma Holdings Inc. (MTNB)
NYSE · Healthcare
Matinas Biopharma Holdings Inc. Net Margin 2014–2023
Current and historical net profit margin for Matinas Biopharma Holdings Inc. (MTNB) over the last 10 years. The current net profit margin for Matinas Biopharma Holdings Inc. as of December 31, 2023 is -2093.25%.
From: 12/31/2014To: 12/31/2023
Revenue
Net Income
Net Margin
Matinas Biopharma Holdings Inc. Net Margin — FAQ
Matinas Biopharma Holdings Inc. (MTNB) net margin over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
What is Matinas Biopharma Holdings Inc.'s net margin?
Matinas Biopharma Holdings Inc. (MTNB) reported net margin of -2093.2% for fiscal 2023.
Where can I see MTNB's net margin history?
The chart and table above show Matinas Biopharma Holdings Inc.'s net margin by year and by quarter, including the growth rate.